The Hematologist

In this installment, Contributing Editor Dr. Loretta J. Nastoupil has a conversation with Dr. Michael Dickinson. They discuss the New England Journal of Medicine article covered by Dr. Nastoupil in her most recent Diffusion article titled, “The Next Wave of T-cell Engagement for the Management of Diffuse Large B-cell Lymphoma.” In the article, Dr. Nastoupil discusses a study that looks at a promising therapy for the management of diffuse large B-cell lymphoma. Read more 

Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

Nesta segunda parte de nossa serie sobre a adaptação das Diretrizes de Prática Clínica da ASH sobre tromboembolismo venoso na América Latina, Dra. Suely Meireles Rezende e Dr. Daniel Días Ribeiro discutem a publicação das diretrizes para prevenção de tromboemboilsmo venoso em pacientes na América Latina. Este podcast é a versão em português de uma série especial com episódios em inglês, espanhol e português. 

Daniel Días Ribeiro, Médico hematologista e Patologista Clínico, Mestre e Doutor pela Faculdade de Medicina – UFMG, Doutor em Epidemiologia Clínica pela Leiden University Medical Center. 

Dr. Suely Meireles Rezende, Médica hematologista, Professora associada da Faculdade de Medicina da universidade federal de Minas Gerais, representando a Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular.

Nossos participantes declararam não ter conflito de interesse com empresas que fabricam e vendem medicamentos ou dispositivos para diagnosticar ou tratar tromboemboilsmo venoso.

Visite www.hematology.org/vte para obter mais informações sobre as diretrizes.

Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

En este episodio de nuestra serie sobre las Guías de Práctica Clínica de ASH, la Dra. Pamela Zuñiga y el Dr. Pedro Pablo García Lázaro Guillermo conversan sobre la importancia clínica de las nuevas Guías de ASH para el Manejo del Tromboembolismo Venoso para América Latina. Este podcast es la versión en español de una serie especial de tres partes con episodios en inglés, español, y portugués.

La Dra. Pamela Zuñiga es hematóloga en la Pontificia Universidad Católica de Chile y participante del Panel LATAM ASH VTE en representación de la Sociedad Chilena de Hematología.

El Dr. Pedro Pablo García Lázaro es hematólogo en la Universidad Privada Antenor Orrego y el Hospital Especializado Víctor Lazarte Echegaray, y participante del Panel LATAM ASH VTE en representación de la Sociedad Peruana de Hematología.

Nuestros participantes han declarado que no tienen conflicto de interés financiero directo alguno con compañías que desarrollan y venden drogas o dispositivos para diagnosticar o tratar tromboembolismo venoso. 

Visite www.hematology.org/vte para obtener más información sobre las guías.

Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

In this installment of our ASH Clinical Practice Guidelines series, Dr. Luis Meillon and Dr. Jaime Pereira have a conversation about the clinical importance of new ASH Guidelines on Venous Thromboembolism in Latin America. This podcast is the English version of a dedicated three-part series in English, Spanish, and Portuguese. 

Dr. Luis Meillon is a hematologist at the ABC Medical Center and panel member representing the Sociedad Mexicana de Trombosis y Hemostasia. He is President of the Agrupación Mexicana para el Estudio de la Hematología. 

Dr. Pereira is Professor at the Department of Hematology-Oncology, School of Medicine, Catholic University of Chile and member of the Latin American panel for ASH VTE Guidelines on behalf of the Chilean Society of Hematology.

None of our speakers has a direct financial conflict of interest with companies that market drugs or devices used to diagnose or treat VTE.

For more information on ASH Guidelines, and how you can get involved, visit www.hematology.org/guidelines. Send in your comments to [email protected]. 

Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

 In this installment, 2023 ASH Summit on Immunotherapies for Hematologic Diseases co-chair Dr. Terry Fry, and The Hematologist Editor-in-Chief Dr. Shaji Kumar have a conversation about what attendees can expect for this year’s summit, taking place in-person only. They discuss the current progress of immunotherapies for treating hematologic malignancies, some of the limitations to bringing these kinds of therapies to patients, manufacturing and regulatory issues, management of toxicities, and more, all to be specifically addressed during the summit.

Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/ 

In this installment, The Hematologist Editor-in-Chief Dr. Shaji Kumar has a conversation with Contributing Editor Dr. Saad Usmani. They discuss Dr. Usmani’s Year’s Best coverage in which he describes the past year’s breakthroughs in immunotherapies for multiple myeloma. The focus in particular on B-cell maturation antigen (BCMA) –targeted therapies, including chimeric antigen receptor T-cells (CAR-Ts) and bispecific T-cell engagers. The editors discuss data presented as recently as the 2022 ASH Annual Meeting, as well as issues surrounding toxicity, patient relapse, and the future of bispecifics and CAR-Ts.

You can access his article online at
https://ashpublications.org/thehematologist/article/doi/10.1182/hem.V20.1.202314/494129/GPRC5D-The-Next-Frontier-for-Immunotherapy-in
Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/ 

In this installment, Contributing Editor Dr. Lori Muffly has a conversation with Dr. Partow Kebriaei. They discuss the Blood article covered by Dr. Muffly in her most recent Diffusion article titled, “Should Minimal Residual Disease Guide the Way? The Evolving Role of Allogeneic Hematopoietic Cell Transplantation for Adults With Ph+ Acute Lymphoblastic Leukemia in First Complete Remission.” In the article, Dr. Muffly explored the study by Drs. Ghobadi, Kebriaei, and colleagues, which examined the impact of allogeneic hematopoietic cell transplantation in adults with Ph+ acute lymphoblastic leukemia achieving deep molecular remission.
You can access his Diffusion article online at https://ashpublications.org/thehematologist/article/doi/10.1182/hem.V19.6.202267/486876/Should-Minimal-Residual-Disease-Guide-the-Way-The.
Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/ 

En este episodio, el Dr. Rubén Mesa entrevista al Dr. Diego Adrianzen-Herrera y la Dra. Joanna Robles en honor del Mes de la Herencia Hispana sobre sus experiencias como hematólogos de ascendencia hispana/latina, la importancia de ASH y un buen mentor en sus carreras, lo que los llevó a estudiar medicina, y la forma de garantizar que la comunidad hispana tenga una voz en el sector de la hematología. Para obtener información adicional, visite www.hematology.org/DEI.
Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

In this installment, Dr. Ruben Mesa leads a conversation in honor of Hispanic Heritage Month, in an interview with Dr. Diego Adrianzen-Herrera and Dr. Joanna Robles. They share their experiences as hematologists of Hispanic/LatinX heritage and discuss the role of mentorship and ASH in their work, what led them to their careers in medicine, and what they as individuals can do to ensure the Hispanic/LatinX community has a voice in the field. Contributing a special introduction to the conversation is Dr. Belinda Avalos, an outspoken leader in diversity, equity, and inclusion in hematology. For more information on the Society's diversity, equity, and inclusion efforts, please visit www.hematology.org/DEI.
Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

In this installment, Contributing Editor Dr. David Rees has a conversation with Drs. Naja Nyffenegger and Vania Manolova. They discuss the Blood article covered by Dr. Rees in his most recent Diffusion article titled, “Iron-restricted Erythropoiesis in Sickle Cell Disease.” In the article, Dr. Rees explored the study by Dr. Nyffenegger and colleagues, which hypothesized that iron restriction via blocking ferroportin might reduce sickle hemoglobin concentration in red blood cells, thereby decreasing hemolysis, improving blood flow, and preventing vaso-occlusive events. You can access his Diffusion article online at https://ashpublications.org/thehematologist/article/doi/10.1182/hem.V19.5.202256/486443/Iron-restricted-Erythropoiesis-in-Sickle-Cell.
Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/